Single-use Bioprocessing Market - Global Forecast 2025-2032

The single-use bioprocessing market is rapidly transforming modern biopharmaceutical manufacturing, offering flexible solutions and efficient alternatives to traditional stainless steel workflows. This comprehensive research is essential for leaders evaluating the impact of operational, regulatory, and technological shifts in single-use applications.

Market Snapshot: Single-Use Bioprocessing Market Growth and Dynamics

The Single-use Bioprocessing Market grew from USD 17.99 billion in 2024 to USD 20.81 billion in 2025. It is expected to continue growing at a CAGR of 16.19%, reaching USD 59.77 billion by 2032. This upward trajectory is driven by the increasing adoption of disposable technologies in response to evolving biologics, cell and gene therapy pipelines, and the demand for agile, contamination-resistant production. Operational flexibility and rapid scale-up capabilities are key market drivers.

Scope & Segmentation of the Single-Use Bioprocessing Market

• Offering: Individual components such as bags and containers, connectors, filtration and separation devices, pumps and flow control, sampling devices and accessories, sensors and probes, tubing (polyethylene, polypropylene, polyvinyl chloride, silicone).
• Single-Use Subassemblies: Bioreactor/process assemblies, media transfer assemblies, sampling assemblies, tubing assemblies/manifolds.
• Workflow Stage: Downstream processing, fill-finish operations, quality control and analytics, upstream processing.
• Bioprocess Mode: Batch, fed-batch, perfusion.
• Subassembly Types: Aseptic transfer sets, filling subassemblies, manifold assemblies, sampling subassemblies, tubing assemblies.
• Manufacturing Processes: 3D printing, adhesive bonding, blow molding, extrusion, injection molding, overmolding, RF welding, thermoforming, ultrasonic welding.
• Applications: Aseptic filling, cell culture, filtration, mixing, purification, sampling, storage.
• End Users: Academic and research institutes, contract manufacturing and research organizations, pharmaceutical and biotechnology companies.
• Regions: Americas (North America, Latin America), Europe, Middle East & Africa (Europe, Middle East, Africa), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan).
• Key Companies Reviewed: Sartorius AG, Thermo Fisher Scientific Inc., Agilitech, Aseptic Group, Avantor Inc., Bionet Servicios Técnicos SL, BioPharma Dynamics Ltd., CellBios Healthcare & Lifesciences Pvt. Ltd., Compagnie de Saint-Gobain, Corning Incorporated, Cytiva by Danaher Corporation, Entegris Inc., Eppendorf SE, Foxx Life Sciences, Freudenberg Group, Getinge AB, Kuehne + Nagel International AG, Lonza Group AG Ltd., Meissner Corporation, Merck KGaA, Mettler-Toledo International Inc., Parker-Hannifin Corporation, PBS Biotech Inc., PharmNXT Biotech, PSG Dover by Dover Corporation, Repligen Corporation, SaniSure, Satake Multimix Corporation, Single Use Support GmbH, Tekni-Plex Inc., Watson-Marlow Fluid Technology Solutions by Spirax Group PLC, AdvantaPure by NewAge Industries.

Key Takeaways for Decision-Makers

• Widespread adoption of single-use systems is driving shorter cycle times, ensuring easier scale-up and addressing the growing complexity of biologics and cell therapy manufacturing.
• Regulatory environments are evolving to support disposable technologies, helping organizations streamline process validation and minimize contamination risks.
• Advanced sensors, digital analytics, and automation are enabling predictive maintenance and process optimization across closed-loop, modular single-use platforms.
• Sustainability mandates are boosting adoption as single-use systems reduce water, energy, and chemical consumption, aligning production practices with environmental initiatives.
• Segment-specific product configurations help academic, contract, and commercial manufacturers balance cost, throughput, and compliance requirements efficiently.
• Regional growth patterns highlight opportunities in Asia-Pacific, where domestic capabilities expand, while Americás and Europe focus on innovation, technology transfer, and eco-efficiency.

Tariff Impact: 2025 US Policy Changes

Recent US tariffs have increased costs for imported single-use materials and equipment, prompting organizations to diversify suppliers and favor domestic or nearshore sourcing. Strategies such as reverse engineering, in-house assembly, and co-development of low-cost, locally sourced materials are strengthening supply chain resilience and cost predictability.

Methodology & Data Sources

This research integrates qualitative insights from senior executives, complemented by review of technical literature and regulatory guidelines. Quantitative findings rely on triangulation between industry expenditure data and reported adoption rates. Local experts contributed to the accuracy of segmentation and regional trend assessments.

Why This Report Matters

• Provides actionable insight to adapt procurement, manufacturing, and sustainability strategies amid rapid changes in the single-use bioprocessing market.
• Enables comparison of technology, workflows, and vendor offerings to guide capital investment and risk mitigation decisions.
• Delivers clarity on the intersection of product innovation, regulatory shifts, and market dynamics across regions and end user segments.

Conclusion

Single-use bioprocessing is reshaping production models and industry standards for flexibility and sustainability. This report offers guidance for senior leaders pursuing operational agility and innovation in an evolving global landscape.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.